These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 33190234)

  • 1. Assessment of adherence to corticosteroids in asthma by drug monitoring or fractional exhaled nitric oxide: A literature review.
    Alahmadi F; Peel A; Keevil B; Niven R; Fowler SJ
    Clin Exp Allergy; 2021 Jan; 51(1):49-62. PubMed ID: 33190234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
    Petsky HL; Cates CJ; Li A; Kynaston JA; Turner C; Chang AB
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006340. PubMed ID: 19821360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating Fractional Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease (COPD) and Asthma-COPD Overlap (ACO): A Scoping Review.
    Mostafavi-Pour-Manshadi SM; Naderi N; Barrecheguren M; Dehghan A; Bourbeau J
    COPD; 2018; 15(4):377-391. PubMed ID: 30067401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy Group.
    Stirling RG; Kharitonov SA; Campbell D; Robinson DS; Durham SR; Chung KF; Barnes PJ
    Thorax; 1998 Dec; 53(12):1030-4. PubMed ID: 10195074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractional exhaled nitric oxide and asthma treatment adherence.
    Butler CA; Heaney LG
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):59-64. PubMed ID: 33369570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath.
    Harnan SE; Tappenden P; Essat M; Gomersall T; Minton J; Wong R; Pavord I; Everard M; Lawson R
    Health Technol Assess; 2015 Oct; 19(82):1-330. PubMed ID: 26484874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma.
    McNicholl DM; Stevenson M; McGarvey LP; Heaney LG
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1102-8. PubMed ID: 23024023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
    Petsky HL; Cates CJ; Li AM; Kynaston JA; Turner C; Chang AB
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006340. PubMed ID: 18425949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhaled nitric oxide levels to guide treatment for children with asthma.
    Petsky HL; Kew KM; Chang AB
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011439. PubMed ID: 27825189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of FeNO in predicting the responsiveness of inhaled corticosteroids in COPD: a systematic review.
    Ramesh R; Georgiou A; Harries T
    Br J Gen Pract; 2024 Jun; 74(suppl 1):. PubMed ID: 38902064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Fractional Exhaled Nitric Oxide Suppression Testing as an Adherence Screening Tool Among Patients With Difficult-to-Control Asthma.
    Barry LE; O'Neill C; Butler C; Chaudhuri R; Heaney LG
    J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1796-1804.e3. PubMed ID: 36940864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children.
    Ghiro L; Zanconato S; Rampon O; Piovan V; Pasquale MF; Baraldi E
    Eur Respir J; 2002 Sep; 20(3):630-4. PubMed ID: 12358339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating fractional exhaled nitric oxide (FeNO) in chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap (ACO): a scoping review protocol.
    Mostafavi-Pour-Manshadi SM; Naderi N; Barrecheguren M; Dehghan A; Bourbeau J
    BMJ Open; 2017 Dec; 7(12):e018954. PubMed ID: 29273668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
    Paro-Heitor ML; Bussamra MH; Saraiva-Romanholo BM; Martins MA; Okay TS; Rodrigues JC
    Pediatr Pulmonol; 2008 Feb; 43(2):134-41. PubMed ID: 18085692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Fractional Exhaled Nitric Oxide Measurement in Clinical Asthma Management.
    Rupani H; Kent BD
    Chest; 2022 Apr; 161(4):906-917. PubMed ID: 34673021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of nonadherence in difficult asthma.
    Gamble J; Stevenson M; McClean E; Heaney LG
    Am J Respir Crit Care Med; 2009 Nov; 180(9):817-22. PubMed ID: 19644048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent elevation of exhaled nitric oxide and modification of corticosteroid therapy in asthma.
    Hirano T; Matsunaga K; Sugiura H; Minakata Y; Koarai A; Akamatsu K; Ichikawa T; Furukawa K; Ichinose M
    Respir Investig; 2013 Jun; 51(2):84-91. PubMed ID: 23790736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Clinical Application of a Prednisolone/Cortisol Assay to Determine Adherence to Maintenance Oral Prednisolone in Severe Asthma.
    Mansur AH; Hassan M; Duffy J; Webster C
    Chest; 2020 Sep; 158(3):901-912. PubMed ID: 32298734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing Asthma Attacks in Children using Exhaled Nitric Oxide as a biomarker to inform treatment strategy: a randomised trial (RAACENO).
    Turner S; Cotton SC; Emele CD; Thomas R; Fielding S; Gaillard EA; de Jongste JC; Morgan H; Neilson AR; Norrie J; Pijnenburg M; Price D; Thomas M
    Trials; 2019 Oct; 20(1):573. PubMed ID: 31585544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interval change in fractional exhaled nitric oxide (FENO) reflects short-term change in adherence following electronic inhaler reminders.
    Tay TR; Yii A; Chan YH; Choo XN
    J Asthma; 2023 Aug; 60(8):1613-1621. PubMed ID: 36647191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.